KLK3 and cancer: In one study, prostate-specific antigen levels were associated with cancer-resistant patients’ vulnerability, economic and educational status, bone metastases, and symptoms.19 Therefore, in terms of primary health care, especially in elderly patients, the clinical status of the patient and prostate specific antigen levels should be evaluated first.